Supplemental Guarantor Information (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Dec. 31, 2012
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income
Revenue	$ 325.7	$ 362.8
Operating costs and expenses	306.5	281.8
Operating (loss) income	19.2	81.0
Interest expense (income), net	47.9	54.4
Other (income) expense, net	(0.3)	1.5
(Loss) income before equity in earnings of subsidiaries and income taxes	(30.3)	25.1
Income tax (benefit) expense	6.4	12.5
Net (loss) income	(36.7)	12.6
Total comprehensive income (loss)	(34.1)	14.0
Preferred stock dividends	2.6	2.6
Net income (loss) applicable to common shareowners	(39.3)	10.0
Condensed Consolidating Balance Sheets
Cash and cash equivalents	5.1	6.9
Other current assets	3.6		11.6
Total current assets	229.5		303.5
Property, plant and equipment, net	873.1		1,587.4
Investment in CyrusOne	500.8		0
Other noncurrent assets	40.0		86.3
Total assets	2,151.5		2,872.4
Current portion of long-term debt	6.6		13.4
Accounts payable	111.7		135.6
Other current liabilities	33.0		40.2
Total current liabilities	322.9		355.4
Long-term debt, less current portion	2,127.4		2,676.0
Other noncurrent liabilities	73.7		176.5
Total liabilities	2,879.3		3,570.6
Shareowners' (deficit) equity	(727.8)		(698.2)
Total liabilities and shareowners' equity (deficit)	2,151.5		2,872.4
Condensed Consolidating Statements of Cash Flows
Cash flows (used in) provided by operating activities	42.3	23.6
Capital expenditures	(50.9)	(84.6)
Proceeds from sale of assets	0.8	0
Cash divested from deconsolidation of CyrusOne	(12.2)	0
Cash flows used in investing activities	(61.9)	(84.6)
Increase in receivables facility, net	2.0	0
Repayment of debt	(3.1)	(4.0)
Common stock repurchase	0	(0.3)
Proceeds from exercise of options and warrants	6.6	0
Other financing activities	(2.3)	1.1
Cash flows provided by (used in) financing activities	1.1	(5.8)
(Decrease) increase in cash and cash equivalents	(18.5)	(66.8)
Cash and cash equivalents at beginning of period	23.6	73.7
Cash and cash equivalents at end of period	5.1	6.9
Notes guaranteed by parent [Member]
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income
Revenue	325.7	362.8
Operating costs and expenses	306.5	281.8
Operating (loss) income	19.2	81.0
Interest expense (income), net	47.9	54.4
Other (income) expense, net	1.6	1.5
(Loss) income before equity in earnings of subsidiaries and income taxes	(30.3)	25.1
Income tax (benefit) expense	6.4	12.5
Equity in earnings of subsidiaries, net of tax	0	0
Net (loss) income	(36.7)	12.6
Other comprehensive income (loss)	2.6	1.4
Total comprehensive income (loss)	(34.1)	14.0
Preferred stock dividends	2.6	2.6
Net income (loss) applicable to common shareowners	(39.3)	10.0
Condensed Consolidating Balance Sheets
Cash and cash equivalents	5.1	6.9
Receivables, net	156.2		199.0
Other current assets	68.2		80.9
Total current assets	229.5		303.5
Property, plant and equipment, net	873.1		1,587.4
Investment in CyrusOne	500.8
Goodwill and intangibles, net	108.2		487.4
Investments in and advances to subsidiaries	0		0
Other noncurrent assets	439.9		494.1
Total assets	2,151.5		2,872.4
Current portion of long-term debt	6.6		13.4
Accounts payable	134.2		135.6
Other current liabilities	182.1		206.4
Total current liabilities	322.9		355.4
Long-term debt, less current portion	2,127.4		2,676.0
Other noncurrent liabilities	429.0		539.2
Intercompany payables	0		0
Total liabilities	2,879.3		3,570.6
Shareowners' (deficit) equity	(727.8)		(698.2)
Total liabilities and shareowners' equity (deficit)	2,151.5		2,872.4
Condensed Consolidating Statements of Cash Flows
Cash flows (used in) provided by operating activities	42.3	23.6
Capital expenditures	(50.9)	(84.6)
Proceeds from sale of assets	0.8	0
Cash divested from deconsolidation of CyrusOne	(12.2)
Other investing activities	0.4	0
Cash flows used in investing activities	(61.9)	(84.6)
Funding between Parent and subsidiaries, net	0	0
Increase in receivables facility, net	2.0	0
Repayment of debt	(3.1)	(4.0)
Common stock repurchase	0	(0.3)
Proceeds from exercise of options and warrants	6.6
Other financing activities	(4.4)	(1.5)
Cash flows provided by (used in) financing activities	1.1	(5.8)
(Decrease) increase in cash and cash equivalents	(18.5)	(66.8)
Cash and cash equivalents at beginning of period	23.6	73.7
Cash and cash equivalents at end of period	5.1	6.9
Notes guaranteed by parent [Member] | Parent Company [Member]
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income
Revenue	0	0
Operating costs and expenses	36.1	7.1
Operating (loss) income	(36.1)	(7.1)
Interest expense (income), net	35.8	40.6
Other (income) expense, net	(0.4)	(0.4)
(Loss) income before equity in earnings of subsidiaries and income taxes	(71.5)	(47.3)
Income tax (benefit) expense	(20.1)	(14.1)
Equity in earnings of subsidiaries, net of tax	14.7	45.8
Net (loss) income	(36.7)	12.6
Other comprehensive income (loss)	2.8	1.4
Total comprehensive income (loss)	(33.9)	14.0
Preferred stock dividends	2.6	2.6
Net income (loss) applicable to common shareowners	(39.3)	10.0
Condensed Consolidating Balance Sheets
Cash and cash equivalents	2.9	1.8
Receivables, net	1.0		1.0
Other current assets	3.9		3.1
Total current assets	7.8		7.9
Property, plant and equipment, net	0.1		0.1
Investment in CyrusOne	0
Goodwill and intangibles, net	0		0
Investments in and advances to subsidiaries	1,441.4		1,449.9
Other noncurrent assets	388.7		384.6
Total assets	1,838.0		1,842.5
Current portion of long-term debt	0		0
Accounts payable	21.4		1.2
Other current liabilities	104.0		85.6
Total current liabilities	125.4		86.8
Long-term debt, less current portion	1,842.1		1,841.7
Other noncurrent liabilities	368.2		383.3
Intercompany payables	230.1		228.9
Total liabilities	2,565.8		2,540.7
Shareowners' (deficit) equity	(727.8)		(698.2)
Total liabilities and shareowners' equity (deficit)	1,838.0		1,842.5
Condensed Consolidating Statements of Cash Flows
Cash flows (used in) provided by operating activities	(27.5)	(36.5)
Capital expenditures	0	0
Proceeds from sale of assets	0	0
Cash divested from deconsolidation of CyrusOne	0
Other investing activities	0	0
Cash flows used in investing activities	0	0
Funding between Parent and subsidiaries, net	24.4	(29.6)
Increase in receivables facility, net	0	0
Repayment of debt	0	0
Common stock repurchase	0	(0.3)
Proceeds from exercise of options and warrants	6.6
Other financing activities	(4.4)	(1.4)
Cash flows provided by (used in) financing activities	26.6	(31.3)
(Decrease) increase in cash and cash equivalents	(0.9)	(67.8)
Cash and cash equivalents at beginning of period	3.8	69.6
Cash and cash equivalents at end of period	2.9	1.8
Notes guaranteed by parent [Member] | Non-Guarantor Subsidiaries [Member]
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income
Revenue	180.5	218.5
Operating costs and expenses	173.4	185.9
Operating (loss) income	7.1	32.6
Interest expense (income), net	7.6	13.9
Other (income) expense, net	0.3	0.8
(Loss) income before equity in earnings of subsidiaries and income taxes	(0.8)	17.9
Income tax (benefit) expense	10.0	6.8
Equity in earnings of subsidiaries, net of tax	0	0
Net (loss) income	(10.8)	11.1
Other comprehensive income (loss)	(0.2)	0
Total comprehensive income (loss)	(11.0)	11.1
Preferred stock dividends	0	0
Net income (loss) applicable to common shareowners	(10.8)	11.1
Condensed Consolidating Balance Sheets
Cash and cash equivalents	0.9	3.9
Receivables, net	155.2		198.0
Other current assets	34.2		43.8
Total current assets	190.3		259.7
Property, plant and equipment, net	206.6		940.6
Investment in CyrusOne	500.8
Goodwill and intangibles, net	105.9		485.1
Investments in and advances to subsidiaries	0		0
Other noncurrent assets	190.8		266.3
Total assets	1,194.4		1,951.7
Current portion of long-term debt	3.4		10.4
Accounts payable	53.3		72.7
Other current liabilities	30.6		69.7
Total current liabilities	87.3		152.8
Long-term debt, less current portion	143.7		693.0
Other noncurrent liabilities	63.9		181.7
Intercompany payables	262.7		276.4
Total liabilities	557.6		1,303.9
Shareowners' (deficit) equity	636.8		647.8
Total liabilities and shareowners' equity (deficit)	1,194.4		1,951.7
Condensed Consolidating Statements of Cash Flows
Cash flows (used in) provided by operating activities	27.6	12.7
Capital expenditures	(18.7)	(62.3)
Proceeds from sale of assets	0	0
Cash divested from deconsolidation of CyrusOne	(12.2)
Other investing activities	0.4	0
Cash flows used in investing activities	(30.5)	(62.3)
Funding between Parent and subsidiaries, net	(13.8)	54.1
Increase in receivables facility, net	2.0	0
Repayment of debt	(2.3)	(3.2)
Common stock repurchase	0	0
Proceeds from exercise of options and warrants	0
Other financing activities	0	(0.1)
Cash flows provided by (used in) financing activities	(14.1)	50.8
(Decrease) increase in cash and cash equivalents	(17.0)	1.2
Cash and cash equivalents at beginning of period	17.9	2.7
Cash and cash equivalents at end of period	0.9	3.9
Notes guaranteed by parent [Member] | Cincinnati Bell Telephone Company [Member]
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income
Revenue	159.3	159.9
Operating costs and expenses	111.1	104.4
Operating (loss) income	48.2	55.5
Interest expense (income), net	4.5	(0.1)
Other (income) expense, net	1.7	1.1
(Loss) income before equity in earnings of subsidiaries and income taxes	42.0	54.5
Income tax (benefit) expense	16.5	19.8
Equity in earnings of subsidiaries, net of tax	0	0
Net (loss) income	25.5	34.7
Other comprehensive income (loss)	0	0
Total comprehensive income (loss)	25.5	34.7
Preferred stock dividends	0	0
Net income (loss) applicable to common shareowners	25.5	34.7
Condensed Consolidating Balance Sheets
Cash and cash equivalents	1.3	1.2
Receivables, net	0		0
Other current assets	30.5		34.4
Total current assets	31.8		36.3
Property, plant and equipment, net	666.4		646.7
Investment in CyrusOne	0
Goodwill and intangibles, net	2.3		2.3
Investments in and advances to subsidiaries	238.9		228.2
Other noncurrent assets	7.1		6.3
Total assets	946.5		919.8
Current portion of long-term debt	3.2		3.0
Accounts payable	59.5		61.7
Other current liabilities	46.8		50.2
Total current liabilities	109.5		114.9
Long-term debt, less current portion	141.6		141.3
Other noncurrent liabilities	144.7		138.6
Intercompany payables	0		0
Total liabilities	395.8		394.8
Shareowners' (deficit) equity	550.7		525.0
Total liabilities and shareowners' equity (deficit)	946.5		919.8
Condensed Consolidating Statements of Cash Flows
Cash flows (used in) provided by operating activities	42.2	47.4
Capital expenditures	(32.2)	(22.3)
Proceeds from sale of assets	0.8	0
Cash divested from deconsolidation of CyrusOne	0
Other investing activities	0	0
Cash flows used in investing activities	(31.4)	(22.3)
Funding between Parent and subsidiaries, net	(10.6)	(24.5)
Increase in receivables facility, net	0	0
Repayment of debt	(0.8)	(0.8)
Common stock repurchase	0	0
Proceeds from exercise of options and warrants	0
Other financing activities	0	0
Cash flows provided by (used in) financing activities	(11.4)	(25.3)
(Decrease) increase in cash and cash equivalents	(0.6)	(0.2)
Cash and cash equivalents at beginning of period	1.9	1.4
Cash and cash equivalents at end of period	1.3	1.2
Notes guaranteed by parent [Member] | Consolidation, Eliminations [Member]
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income
Revenue	(14.1)	(15.6)
Operating costs and expenses	(14.1)	(15.6)
Operating (loss) income	0	0
Interest expense (income), net	0	0
Other (income) expense, net	0	0
(Loss) income before equity in earnings of subsidiaries and income taxes	0	0
Income tax (benefit) expense	0	0
Equity in earnings of subsidiaries, net of tax	(14.7)	(45.8)
Net (loss) income	(14.7)	(45.8)
Other comprehensive income (loss)	0	0
Total comprehensive income (loss)	(14.7)	(45.8)
Preferred stock dividends	0	0
Net income (loss) applicable to common shareowners	(14.7)	(45.8)
Condensed Consolidating Balance Sheets
Cash and cash equivalents	0	0
Receivables, net	0		0
Other current assets	(0.4)		(0.4)
Total current assets	(0.4)		(0.4)
Property, plant and equipment, net	0		0
Investment in CyrusOne	0
Goodwill and intangibles, net	0		0
Investments in and advances to subsidiaries	(1,680.3)		(1,678.1)
Other noncurrent assets	(146.7)		(163.1)
Total assets	(1,827.4)		(1,841.6)
Current portion of long-term debt	0		0
Accounts payable	0		0
Other current liabilities	0.7		0.9
Total current liabilities	0.7		0.9
Long-term debt, less current portion	0		0
Other noncurrent liabilities	(147.8)		(164.4)
Intercompany payables	(492.8)		(505.3)
Total liabilities	(639.9)		(668.8)
Shareowners' (deficit) equity	(1,187.5)		(1,172.8)
Total liabilities and shareowners' equity (deficit)	(1,827.4)		(1,841.6)
Condensed Consolidating Statements of Cash Flows
Cash flows (used in) provided by operating activities	0	0
Capital expenditures	0	0
Proceeds from sale of assets	0	0
Cash divested from deconsolidation of CyrusOne	0
Other investing activities	0	0
Cash flows used in investing activities	0	0
Funding between Parent and subsidiaries, net	0	0
Increase in receivables facility, net	0	0
Repayment of debt	0	0
Common stock repurchase	0	0
Proceeds from exercise of options and warrants	0
Other financing activities	0	0
Cash flows provided by (used in) financing activities	0	0
(Decrease) increase in cash and cash equivalents	0	0
Cash and cash equivalents at beginning of period	0	0
Cash and cash equivalents at end of period	0	0
Notes guaranteed by subsidiaries [Member]
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income
Revenue	325.7	362.8
Operating costs and expenses	306.5	281.8
Operating (loss) income	19.2	81.0
Interest expense (income), net	47.9	54.4
Other (income) expense, net	1.6	1.5
(Loss) income before equity in earnings of subsidiaries and income taxes	(30.3)	25.1
Income tax (benefit) expense	6.4	12.5
Equity in earnings of subsidiaries, net of tax	0	0
Net (loss) income	(36.7)	12.6
Other comprehensive income (loss)	2.6	1.4
Total comprehensive income (loss)	(34.1)	14.0
Preferred stock dividends	2.6	2.6
Net income (loss) applicable to common shareowners	(39.3)	10.0
Condensed Consolidating Balance Sheets
Cash and cash equivalents	5.1	6.9
Receivables, net	156.2		199.0
Other current assets	68.2		80.9
Total current assets	229.5		303.5
Property, plant and equipment, net	873.1		1,587.4
Investment in CyrusOne	500.8		0
Goodwill and intangibles, net	108.2		487.4
Investments in and advances to subsidiaries	0		0
Other noncurrent assets	439.9		494.1
Total assets	2,151.5		2,872.4
Current portion of long-term debt	6.6		13.4
Accounts payable	134.2		135.6
Other current liabilities	182.1		206.4
Total current liabilities	322.9		355.4
Long-term debt, less current portion	2,127.4		2,676.0
Other noncurrent liabilities	429.0		539.2
Intercompany payables	0		0
Total liabilities	2,879.3		3,570.6
Shareowners' (deficit) equity	(727.8)		(698.2)
Total liabilities and shareowners' equity (deficit)	2,151.5		2,872.4
Condensed Consolidating Statements of Cash Flows
Cash flows (used in) provided by operating activities	42.3	23.6
Capital expenditures	(50.9)	(84.6)
Proceeds from sale of assets	0.8	0
Cash divested from deconsolidation of CyrusOne	(12.2)
Other investing activities	0.4	0
Cash flows used in investing activities	(61.9)	(84.6)
Funding between Parent and subsidiaries, net	0	0
Increase in receivables facility, net	2.0	0
Repayment of debt	(3.1)	(4.0)
Common stock repurchase	0	(0.3)
Proceeds from exercise of options and warrants	6.6
Other financing activities	(4.4)	(1.5)
Cash flows provided by (used in) financing activities	1.1	(5.8)
(Decrease) increase in cash and cash equivalents	(18.5)	(66.8)
Cash and cash equivalents at beginning of period	23.6	73.7
Cash and cash equivalents at end of period	5.1	6.9
Notes guaranteed by subsidiaries [Member] | Parent Company [Member]
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income
Revenue	0	0
Operating costs and expenses	36.1	7.1
Operating (loss) income	(36.1)	(7.1)
Interest expense (income), net	35.8	40.6
Other (income) expense, net	(0.4)	(0.4)
(Loss) income before equity in earnings of subsidiaries and income taxes	(71.5)	(47.3)
Income tax (benefit) expense	(20.1)	(14.1)
Equity in earnings of subsidiaries, net of tax	14.7	45.8
Net (loss) income	(36.7)	12.6
Other comprehensive income (loss)	2.8	1.4
Total comprehensive income (loss)	(33.9)	14.0
Preferred stock dividends	2.6	2.6
Net income (loss) applicable to common shareowners	(39.3)	10.0
Condensed Consolidating Balance Sheets
Cash and cash equivalents	2.9	1.8
Receivables, net	1.0		1.0
Other current assets	3.9		3.1
Total current assets	7.8		7.9
Property, plant and equipment, net	0.1		0.1
Investment in CyrusOne	0		0
Goodwill and intangibles, net	0		0
Investments in and advances to subsidiaries	1,441.4		1,449.9
Other noncurrent assets	388.7		384.6
Total assets	1,838.0		1,842.5
Current portion of long-term debt	0		0
Accounts payable	21.4		1.2
Other current liabilities	104.0		85.6
Total current liabilities	125.4		86.8
Long-term debt, less current portion	1,842.1		1,841.7
Other noncurrent liabilities	368.2		383.3
Intercompany payables	230.1		228.9
Total liabilities	2,565.8		2,540.7
Shareowners' (deficit) equity	(727.8)		(698.2)
Total liabilities and shareowners' equity (deficit)	1,838.0		1,842.5
Condensed Consolidating Statements of Cash Flows
Cash flows (used in) provided by operating activities	(27.5)	(36.5)
Capital expenditures	0	0
Proceeds from sale of assets	0	0
Cash divested from deconsolidation of CyrusOne	0
Other investing activities	0	0
Cash flows used in investing activities	0	0
Funding between Parent and subsidiaries, net	24.4	(29.6)
Increase in receivables facility, net	0	0
Repayment of debt	0	0
Common stock repurchase	0	(0.3)
Proceeds from exercise of options and warrants	6.6
Other financing activities	(4.4)	(1.4)
Cash flows provided by (used in) financing activities	26.6	(31.3)
(Decrease) increase in cash and cash equivalents	(0.9)	(67.8)
Cash and cash equivalents at beginning of period	3.8	69.6
Cash and cash equivalents at end of period	2.9	1.8
Notes guaranteed by subsidiaries [Member] | Guarantor Subsidiaries [Member]
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income
Revenue	175.7	175.6
Operating costs and expenses	170.1	156.3
Operating (loss) income	5.6	19.3
Interest expense (income), net	3.9	1.7
Other (income) expense, net	4.7	2.7
(Loss) income before equity in earnings of subsidiaries and income taxes	(3.0)	14.9
Income tax (benefit) expense	9.5	4.4
Equity in earnings of subsidiaries, net of tax	0.7	(1.1)
Net (loss) income	(11.8)	9.4
Other comprehensive income (loss)	0	0
Total comprehensive income (loss)	(11.8)	9.4
Preferred stock dividends	0	0
Net income (loss) applicable to common shareowners	(11.8)	9.4
Condensed Consolidating Balance Sheets
Cash and cash equivalents	0.4	0.5
Receivables, net	7.4		1.2
Other current assets	30.0		27.7
Total current assets	37.8		29.2
Property, plant and equipment, net	204.6		220.9
Investment in CyrusOne	500.8		0
Goodwill and intangibles, net	105.9		106.4
Investments in and advances to subsidiaries	340.3		506.4
Other noncurrent assets	192.0		218.5
Total assets	1,381.4		1,081.4
Current portion of long-term debt	3.1		3.9
Accounts payable	73.6		90.2
Other current liabilities	32.2		33.6
Total current liabilities	108.9		127.7
Long-term debt, less current portion	87.9		88.4
Other noncurrent liabilities	65.8		90.6
Intercompany payables	178.2		160.0
Total liabilities	440.8		466.7
Shareowners' (deficit) equity	940.6		614.7
Total liabilities and shareowners' equity (deficit)	1,381.4		1,081.4
Condensed Consolidating Statements of Cash Flows
Cash flows (used in) provided by operating activities	(8.4)	(34.9)
Capital expenditures	(11.0)	(9.5)
Proceeds from sale of assets	0	0
Cash divested from deconsolidation of CyrusOne	0
Other investing activities	0	0
Cash flows used in investing activities	(11.0)	(9.5)
Funding between Parent and subsidiaries, net	21.0	45.9
Increase in receivables facility, net	0	0
Repayment of debt	(1.5)	(1.6)
Common stock repurchase	0	0
Proceeds from exercise of options and warrants	0
Other financing activities	0	(0.1)
Cash flows provided by (used in) financing activities	19.5	44.2
(Decrease) increase in cash and cash equivalents	0.1	(0.2)
Cash and cash equivalents at beginning of period	0.3	0.7
Cash and cash equivalents at end of period	0.4	0.5
Notes guaranteed by subsidiaries [Member] | Non-Guarantor Subsidiaries [Member]
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income
Revenue	164.1	202.8
Operating costs and expenses	114.4	134.0
Operating (loss) income	49.7	68.8
Interest expense (income), net	8.2	12.1
Other (income) expense, net	(2.7)	(0.8)
(Loss) income before equity in earnings of subsidiaries and income taxes	44.2	57.5
Income tax (benefit) expense	17.0	22.2
Equity in earnings of subsidiaries, net of tax	0	0
Net (loss) income	27.2	35.3
Other comprehensive income (loss)	(0.2)	0
Total comprehensive income (loss)	27.0	35.3
Preferred stock dividends	0	0
Net income (loss) applicable to common shareowners	27.2	35.3
Condensed Consolidating Balance Sheets
Cash and cash equivalents	1.8	4.6
Receivables, net	147.8		196.8
Other current assets	34.7		50.5
Total current assets	184.3		266.8
Property, plant and equipment, net	668.4		1,366.4
Investment in CyrusOne	0		0
Goodwill and intangibles, net	2.3		381.0
Investments in and advances to subsidiaries	221.5		192.5
Other noncurrent assets	5.9		54.1
Total assets	1,082.4		2,260.8
Current portion of long-term debt	3.5		9.5
Accounts payable	39.2		44.2
Other current liabilities	45.2		86.3
Total current liabilities	87.9		140.0
Long-term debt, less current portion	197.4		745.9
Other noncurrent liabilities	142.8		229.7
Intercompany payables	85.1		102.6
Total liabilities	513.2		1,218.2
Shareowners' (deficit) equity	569.2		1,042.6
Total liabilities and shareowners' equity (deficit)	1,082.4		2,260.8
Condensed Consolidating Statements of Cash Flows
Cash flows (used in) provided by operating activities	78.2	95.0
Capital expenditures	(39.9)	(75.1)
Proceeds from sale of assets	0.8	0
Cash divested from deconsolidation of CyrusOne	(12.2)
Other investing activities	0.4	0
Cash flows used in investing activities	(50.9)	(75.1)
Funding between Parent and subsidiaries, net	(45.4)	(16.3)
Increase in receivables facility, net	2.0	0
Repayment of debt	(1.6)	(2.4)
Common stock repurchase	0	0
Proceeds from exercise of options and warrants	0
Other financing activities	0	0
Cash flows provided by (used in) financing activities	(45.0)	(18.7)
(Decrease) increase in cash and cash equivalents	(17.7)	1.2
Cash and cash equivalents at beginning of period	19.5	3.4
Cash and cash equivalents at end of period	1.8	4.6
Notes guaranteed by subsidiaries [Member] | Consolidation, Eliminations [Member]
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income
Revenue	(14.1)	(15.6)
Operating costs and expenses	(14.1)	(15.6)
Operating (loss) income	0	0
Interest expense (income), net	0	0
Other (income) expense, net	0	0
(Loss) income before equity in earnings of subsidiaries and income taxes	0	0
Income tax (benefit) expense	0	0
Equity in earnings of subsidiaries, net of tax	(15.4)	(44.7)
Net (loss) income	(15.4)	(44.7)
Other comprehensive income (loss)	0	0
Total comprehensive income (loss)	(15.4)	(44.7)
Preferred stock dividends	0	0
Net income (loss) applicable to common shareowners	(15.4)	(44.7)
Condensed Consolidating Balance Sheets
Cash and cash equivalents	0	0
Receivables, net	0		0
Other current assets	(0.4)		(0.4)
Total current assets	(0.4)		(0.4)
Property, plant and equipment, net	0		0
Investment in CyrusOne	0		0
Goodwill and intangibles, net	0		0
Investments in and advances to subsidiaries	(2,003.2)		(2,148.8)
Other noncurrent assets	(146.7)		(163.1)
Total assets	(2,150.3)		(2,312.3)
Current portion of long-term debt	0		0
Accounts payable	0		0
Other current liabilities	0.7		0.9
Total current liabilities	0.7		0.9
Long-term debt, less current portion	0		0
Other noncurrent liabilities	(147.8)		(164.4)
Intercompany payables	(493.4)		(491.5)
Total liabilities	(640.5)		(655.0)
Shareowners' (deficit) equity	(1,509.8)		(1,657.3)
Total liabilities and shareowners' equity (deficit)	(2,150.3)		(2,312.3)
Condensed Consolidating Statements of Cash Flows
Cash flows (used in) provided by operating activities	0	0
Capital expenditures	0	0
Proceeds from sale of assets	0	0
Cash divested from deconsolidation of CyrusOne	0
Other investing activities	0	0
Cash flows used in investing activities	0	0
Funding between Parent and subsidiaries, net	0	0
Increase in receivables facility, net	0	0
Repayment of debt	0	0
Common stock repurchase	0	0
Proceeds from exercise of options and warrants	0
Other financing activities	0	0
Cash flows provided by (used in) financing activities	0	0
(Decrease) increase in cash and cash equivalents	0	0
Cash and cash equivalents at beginning of period	0	0
Cash and cash equivalents at end of period	$ 0	$ 0